Evidence map›Paper›PMID 34641297›Full record

ReviewMolecules (Basel, Switzerland)2021

Pursuing High-Resolution Structures of Nicotinic Acetylcholine Receptors: Lessons Learned from Five Decades.

Manuel Delgado-Vélez, Orestes Quesada, Juan C Villalobos-Santos, Rafael Maldonado-Hernández, Guillermo Asmar-Rovira, Raymond C Stevens, José Antonio Lasalde-Dominicci

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Nicotine: From Discovery to Biological Effects.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manuel Delgado-VélezDepartment of Biology, Rio Piedras Campus, University of Puerto Rico, San Juan 00931, Puerto Rico.
Orestes QuesadaClinical Bioreagent Center, Molecular Sciences Research Center, University of Puerto Rico, San Juan 00926, Puerto Rico.
Juan C Villalobos-SantosDepartment of Biology, Rio Piedras Campus, University of Puerto Rico, San Juan 00931, Puerto Rico.
Rafael Maldonado-HernándezClinical Bioreagent Center, Molecular Sciences Research Center, University of Puerto Rico, San Juan 00926, Puerto Rico.
Guillermo Asmar-RoviraIndependent Researcher, Ambler, PA 19002, USA.
Raymond C StevensMichelson Center for Convergent Bioscience, Department of Biological Sciences, Bridge Institute, University of Southern California, Los Angeles, CA 90007, USA.
José Antonio Lasalde-DominicciDepartment of Biology, Rio Piedras Campus, University of Puerto Rico, San Juan 00931, Puerto Rico.

Funding

Upgrade Laboratories Facilities at UPR-Rio PiedrasR25GM061151 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2001 to 2023
$32.5M
The Role of Sensory Input to Mammalian Locomotion After the Loss of supraspinal.P20GM103642 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LASALDE-DOMINICCI, JOSE ANTONIO · 2013 to 2023
$20.6M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Research Projects CoreP30GM149367 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI JOSE Antonio LASALDE-DOMINICCI · 2023 to 2026
$5.6M
A lipid-based approach towards the nAChR high resolution structureR01GM098343 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI LASALDE-DOMINICCI, JOSE ANTONIO · 2013 to 2018
$1.1M
NIGMS NIH HHS 5R25GM061151NIGMS NIH HHS P20 GM103642NIGMS NIH HHS P20GM103642NIGMS NIH HHS P30 GM149367NIGMS NIH HHS P41 GM103311NIGMS NIH HHS R01 GM098343NIGMS NIH HHS R01GM098343NIGMS NIH HHS R25 GM061151
6 · The paper itself

Abstract

Since their discovery, nicotinic acetylcholine receptors (nAChRs) have been extensively studied to understand their function, as well as the consequence of alterations leading to disease states. Importantly, these receptors represent pharmacological targets to treat a number of neurological and neurodegenerative disorders. Nevertheless, their therapeutic value has been limited by the absence of high-resolution structures that allow for the design of more specific and effective drugs. This article offers a comprehensive review of five decades of research pursuing high-resolution structures of nAChRs. We provide a historical perspective, from initial structural studies to the most recent X-ray and cryogenic electron microscopy (Cryo-EM) nAChR structures. We also discuss the most relevant structural features that emerged from these studies, as well as perspectives in the field.

Indexed as

AnimalsCryoelectron MicroscopyCrystallography, X-RayHumansModels, MolecularMolecular Targeted TherapyNervous System DiseasesProtein ConformationReceptors, NicotinicReceptors, Nicotiniccholesterolcryogenic electron microscopycrystallographycrystal structuredetergentsligand-gated ion channellipidsnicotinic acetylcholine receptorsTorpedo californicaTorpedo marmorata

Identifiers

PMID34641297
PMCPMC8510392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.